Double trouble: how c-MET and HER2 fuel bladder cancer progression
Abstract Background Bladder cancer is still a prevalent, heterogeneous, and challenging disease. Most cases are non-muscle invasive and carry a significant risk of recurrence and progression despite current advances in therapeutic options. Main c-MET and HER2 belong to the receptor tyrosine kinase f...
| الحاوية / القاعدة: | Egyptian Journal of Medical Human Genetics |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
SpringerOpen
2024-12-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s43042-024-00618-y |